WEB™ SL & WEB™ SLS

Intrasaccular Devices

Product Benefits

The WEB™ Embolization System is first-in-class intrasaccular technology offering a single-device treatment alternative to endovascular coils and complex stenting procedures. The intrasaccular embolization system minimizes the need for a dual antiplatelet regimen required for intraluminal therapies.

  • Single-device solution for complex aneurysms

  • The WEB device is constructed from a unique MicroBraid that facilitates ease-of-use and treatment durability

  • Multiple GCP studies prove the safety and effectiveness of the device in a challenging aneurysm category2 4 

The WEB System Animation

WEB SL Intrasaccular Device

WEB SL Intrasaccular Device

WEB SL Intrasaccular Device

WEB SL Intrasaccular Device

WEB SLS Intrasaccular Device

WEB SLS Intrasaccular Device

WEB SLS Intrasaccular Device

WEB SLS Intrasaccular Device

Specifications

Product Compatibility:

The VIA microcatheter was specially designed for dedicated use with the WEB device to maximize system performance. The VIA microcatheter ensures smooth delivery, controlled deployment and reliable retrieval of the WEB device.

WEB™ Delivery System

WEB™ Delivery System

The WEB Detachment Controller is specifically designed to detach all WEB Aneurysm Embolization Systems.

Learn more

Related Products

Microcatheters

VIA™

Microcatheters

Learn More

FDA PMA Approval

The WEB System is the first and only PMA approved device in the new category of intrasaccular flow disruptors for aneurysm embolization.

Read the Press Release

Clinical Education & Bibliography

To find clinical trials, studies and registries involving the WEB device please visit clinicaltrials.gov. To view the complete bibliography see the link below.

Go to the Bibliography

How to Order

Visit our contact page for information on how to place an order by phone, fax or email.

Learn More

  1. 1

    Pierot L et al. Clinical and Anatomical Follow-up in Patients With Aneurysms Treated With WEB Device: One-year Follow-up Report in the Cumulated Population of 2 Prospective, Multicenter Series (WEBCAST, French Observatory). Neurosurgery Jan 2016, 78:133-141

  2. 2

    Pierot L, Moret J, Barreau X, et al. Safety and efficacy of aneurysm treatment with WEB in the cumulative population of three prospective, multicenter series. J Neurointerv Surg 2017

  3. 3

    *Adequate Occlusion: complete occlusion or neck remnant

     

    Pierot L, Moret J, Barreau X, et al. Safety and efficacy of aneurysm treatment with WEB in the cumulative population of three prospective, multicenter series. J Neurointerv Surg 2017.

     

  4. 4

    Fiorella D, Molyneux A, Coon A, et al. Demographic, procedural and 30-day safety results from the WEB Intra-saccular Therapy Study (WEB-IT). J Neurointerv Surg 2017;9:1191-6

TITLE

ADDRESS_TEXT

    PHONE LIST